(Ontores Biotechnology, Zhejiang, China), monomers for nanoMIP synthesis
(Sigma, Gillingham, UK), sodium hydroxide (Sigma), ammonium persulfate
(Sigma), mercaptoundecanoic acid (Sigma), ethanolamine hydrochloride
(Sigma), bovine serum albumin (BSA, Sigma), Pluronic solution (Sigma),
4-ABA (Fisher Scientific, Loughborough, UK), EDC (Fisher Scientific),
NHS (Fisher Scientific), ferricyanide (Sigma), ferrocyanide (Sigma),
potassium chloride (KCl, Sigma), hydrogen peroxide (30%, Sigma), ammonia
solution (25%, VWR International, Leicestershire, UK), PBS tablets
(Sigma), the alpha variant of the SARS-CoV-2 spike protein (The Native
Antigen Company, Kidlington, UK), the delta variant of the spike protein
(Abbexa, Cambridge, UK), HSA (Sigma), and IL-6 (Bio-Rad, Watford,
UK) were used as received. The SARS-CoV-2 RBD and ORF8 were provided
by the Medical Research Council Protein Phosphorylation and Ubiquitylation
Unit (Dundee, UK). PBS solutions were prepared with deionized (DI)
water, and AFM experiments were performed using Milli-Q water (both
with a resistivity of ≥18.2 MΩ cm).